Transgender individuals who are assigned male at birth and wish to undergo a male-to-female (MTF) transition often use hormone therapy to develop more feminine physical characteristics, including breast growth. The primary hormones used for MTF breast development are estrogen and anti-androgens.
- Estrogen: Estrogen is the primary hormone responsible for the development of female secondary sex characteristics. When taken as part of hormone therapy for MTF individuals, estrogen promotes breast growth, softer skin, reduced body hair, and fat redistribution to more feminine patterns.
- Anti-Androgens: Anti-androgens are medications used to block the effects of male hormones (androgens) like testosterone. By reducing testosterone levels, anti-androgens allow estrogen to have a more significant impact on the body and help to prevent further masculinization.
The dosage and specific regimen of hormone therapy will be determined by a healthcare provider with expertise in transgender healthcare. Hormone therapy is typically initiated after comprehensive medical evaluation, including blood tests and discussions about potential risks and benefits.
It’s important to note that hormone therapy for transgender individuals should only be undertaken under the supervision of qualified healthcare professionals, as there may be potential side effects and health risks associated with hormone use. Regular monitoring and follow-up visits are essential to ensure the safety and effectiveness of hormone therapy.